Ligand validation:7JU7

G65: Masitinib

G65 is a Ligand Of Interest in 7JU7 designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7JU7_G65_A_401	11%	78%	0.281	0.798	0.36	0.53	-	-	1	0	100%	1
7TVX_G65_A_401	14%	2%	0.27	0.818	5.32	1.3	29	6	1	0	100%	1
5MQL_G65_A_302	3%	12%	0.428	0.748	2.41	1.64	7	9	3	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.